These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3965163)

  • 1. Contragestational profile of the tumor-inhibiting agent, L-alanosine, in the rat and the hamster.
    Galliani G; Assandri A; Barone D; Grandi M; Mistrello G; Lancini GC
    Cancer Chemother Pharmacol; 1985; 14(1):74-8. PubMed ID: 3965163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the antimetabolite of L-alanosine, L-alanosyl-5-amino-4-imidazolecarboxylic acid ribonucleotide, in tumors and assessment of its inhibition of adenylosuccinate synthetase.
    Tyagi AK; Cooney DA
    Cancer Res; 1980 Dec; 40(12):4390-7. PubMed ID: 7438071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel synergistic effect of alanosine and guanine on adenine nucleotide synthesis in mammalian cells. Alanosine as a useful probe for investigating purine nucleotide metabolism.
    Gupta RS
    J Cell Physiol; 1980 Aug; 104(2):241-8. PubMed ID: 7410492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alanosine toxicity in Novikoff rat hepatoma cells due to inhibition of the conversion of inosine monophosphate to adenosine monophosphate.
    Graff JC; Plagemann PG
    Cancer Res; 1976 Apr; 36(4):1428-40. PubMed ID: 177207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of gene expression profiles predicting tumor cell response to L-alanosine.
    Efferth T; Gebhart E; Ross DD; Sauerbrey A
    Biochem Pharmacol; 2003 Aug; 66(4):613-21. PubMed ID: 12906926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of fluoropyrimidine metabolism in L1210 cells by L-alanosine.
    Heimer R; Goldberg D; Cadman E
    Biochem Pharmacol; 1983 Jan; 32(2):199-206. PubMed ID: 6870949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EFA (9-beta-D-erythrofuranosyladenine) is an effective salvage agent for methylthioadenosine phosphorylase-selective therapy of T-cell acute lymphoblastic leukemia with L-alanosine.
    Batova A; Cottam H; Yu J; Diccianni MB; Carrera CJ; Yu AL
    Blood; 2006 Feb; 107(3):898-903. PubMed ID: 16234352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-(1,1'-Biphenyl-4-yl)- 1,2,4-triazole[5,1-a] isoquinoline (L 14105), a potential orally active contragestational agent for the bitch: studies in the rat, hamster and dog.
    Galliani G; Guzzi U; Tarzia G; Assandri A
    J Vet Pharmacol Ther; 1986 Sep; 9(3):246-53. PubMed ID: 3761415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of the toxicity of L-alanosine to various organs of the mouse.
    Tyagi AK; Thake DC; McGee E; Cooney DA
    Toxicology; 1981; 21(1):59-69. PubMed ID: 7281196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased tumor control rates in murine fibrosarcoma by combined therapy with L-alanosine and radiation.
    Hong SS; Alfieri AA; Kim SH; Kim JH
    Jpn J Cancer Res; 1989 Jun; 80(6):592-6. PubMed ID: 2503478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic disposition of DL-alanosine in mice, rats, dogs, and monkeys.
    Kelley JM; Adamson RH; Cooney DA; Jayaram HN; Anandaraj S
    Cancer Treat Rep; 1977 Nov; 61(8):1471-84. PubMed ID: 411570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the mode of action of a new contragestational agent (DL 111-IT).
    Galliani G; Luzzani F; Colombo G; Conz A; Mistrello L; Barone D; Lancini GC; Assandri A
    Contraception; 1986 Mar; 33(3):263-83. PubMed ID: 2424668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II multicenter study of L-alanosine, a potent inhibitor of adenine biosynthesis, in patients with MTAP-deficient cancer.
    Kindler HL; Burris HA; Sandler AB; Oliff IA
    Invest New Drugs; 2009 Feb; 27(1):75-81. PubMed ID: 18618081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro biological evaluation of N-[(5-amino-1-beta-D-ribofuranosyl-1H-imidazol-4-yl)carbonyl]-3- (hydroxynitrosamino)-L-alanine (L-alanosine AICO ribonucleoside).
    Strazzolini P; Malabarba A; Ferrari P; Grandi M; Cavalleri B
    J Med Chem; 1984 Oct; 27(10):1295-9. PubMed ID: 6592359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alanosine (UCSD).
    Yu J
    Curr Opin Investig Drugs; 2001 Nov; 2(11):1623-30. PubMed ID: 11763167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical pharmacology, metabolism, and mechanism of action of L-alanosine, a novel, natural antitumor agent.
    Tyagi AK; Cooney DA
    Adv Pharmacol Chemother; 1984; 20():69-121. PubMed ID: 6398969
    [No Abstract]   [Full Text] [Related]  

  • 17. Contragestational effects of DL-alpha-difluoro-methylornithine, an irreversible inhibitor of ornithine decarboxylase, in the hamster.
    Galliani G; Colombo G; Luzzani F
    Contraception; 1983 Aug; 28(2):159-70. PubMed ID: 6416746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T-cell acute lymphoblastic leukemia in vitro.
    Batova A; Diccianni MB; Omura-Minamisawa M; Yu J; Carrera CJ; Bridgeman LJ; Kung FH; Pullen J; Amylon MD; Yu AL
    Cancer Res; 1999 Apr; 59(7):1492-7. PubMed ID: 10197619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of 14C-labeled dicarboxylic amino acids in hepatocytes and hepatoma cells.
    Koch MR; Lea MA
    Cancer Res; 1981 Aug; 41(8):3065-70. PubMed ID: 7248963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase I study of the combination N-(phosphonacetyl)-L-aspartate (PALA, NSC-224131) and L-alanosine (NSC-153353) in patients with advanced cancer.
    Creagan ET; O'Connell MJ; Kovach JS
    Cancer; 1983 Aug; 52(4):615-8. PubMed ID: 6861099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.